Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on June 8, 2006

Stroke. 2006
Published online before print June 8, 2006, doi: 10.1161/01.STR.0000227236.84546.5a
A more recent version of this article appeared on July 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/7/1850    most recent
01.STR.0000227236.84546.5av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baumbach, G. L.
Right arrow Articles by Faraci, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baumbach, G. L.
Right arrow Articles by Faraci, F. M.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Hypertrophy

Submitted on March 16, 2006
Accepted on April 6, 2006

Hypertrophy of Cerebral Arterioles in Mice Deficient in Expression of the Gene for CuZn Superoxide Dismutase

Gary L. Baumbach MD*; Sean P. Didion PhD; and Frank M. Faraci PhD

From the Department of Pathology (G.L.B.), University of Iowa College of Medicine & Cardiovascular Center, Iowa City, IA; and the Department of Internal Medicine (S.P.D., F.M.F.), University of Iowa College of Medicine & Cardiovascular Center, Iowa City, IA.

* To whom correspondence should be addressed. E-mail: g-baumbach{at}uiowa.edu.

Background and Purpose--Reactive oxygen species are believed to be an important determinant of vascular growth. We examined effects of genetic deficiency of copper-zinc superoxide dismutase (CuZnSOD; SOD1) on structure and function of cerebral arterioles.

Methods--Systemic arterial pressure (SAP) and cross-sectional area of the vessel wall (CSA) and superoxide (O2-) levels (relative fluorescence of ethidium [ETH]) were examined in maximally dilated cerebral arterioles in mice with targeted disruption of one (+/-) or both (-/-) genes encoding CuZnSOD. Wild-type littermates served as controls. Vasodilator responses were tested in separate groups of mice.

Results--CSA and ETH were significantly increased (P<0.05) in both CuZnSOD+/- and CuZnSOD-/- mice (CSA=435±24 and 541±48 µm2; ETH=18±1 and 34±2%) compared with wild-type mice (CSA=327±28 µm2; ETH=6%). Furthermore, the increases in CSA and ETH relative to wild-type mice were significantly greater (P<0.05) in CuZnSOD-/- mice than in CuZnSOD+/- mice (CSA=108 versus 214 µm2; ETH=12 versus 28%). In addition, dilatation of cerebral arterioles in response to acetylcholine, but not nitroprusside, was reduced by {approx}25% in CuZnSOD+/- (P<0.075) and 50% in CuZnSOD-/- mice (P<0.05) compared with wild-type mice.

Conclusions--Cerebral arterioles in CuZnSOD+/- and CuZnSOD-/- mice undergo marked hypertrophy. These findings provide the first direct evidence in any blood vessel that CuZnSOD normally inhibits vascular hypertrophy suggesting that CuZnSOD plays a major role in regulation of cerebral vascular growth. The findings also suggest a gene dosing effect of CuZnSOD for increases in O2-, induction of cerebral vascular hypertrophy and impaired endothelium-dependent dilatation.


Key words: cerebral arteries • hypertrophy • reactive oxygen species • superoxide dismutase




This article has been cited by other articles:


Home page
HypertensionHome page
F. M. Faraci
Surviving the Remodel: The Impact of Hypertension During Pregnancy
Hypertension, April 1, 2008; 51(4): 995 - 996.
[Full Text] [PDF]


Home page
HypertensionHome page
A. M. Beyer, G. L. Baumbach, C. M. Halabi, M. L. Modrick, C. M. Lynch, T. D. Gerhold, S. M. Ghoneim, W. J. de Lange, H. L. Keen, Y.-S. Tsai, et al.
Interference With PPAR{gamma} Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling
Hypertension, April 1, 2008; 51(4): 867 - 871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Didion, C. M. Lynch, and F. M. Faraci
Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1579 - H1583.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D.-D. Chen and A. F. Chen
CuZn Superoxide Dismutase Deficiency: Culprit of Accelerated Vascular Aging Process
Hypertension, December 1, 2006; 48(6): 1026 - 1028.
[Full Text] [PDF]